NCT04197713 2026-04-29Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance, STAR StudyNational Cancer Institute (NCI)Phase 1 Active not recruiting13 enrolled 13 charts